458 Inorganic Chemistry, Vol. 49, No. 2, 2010
Chattopadhyay et al.
co-ligand. This effect enables rudimentary control of
co-ligand bonding through steric contact, in modest analogy
to typically elegant allosteric active site control achieved in
metalloenzymes through all levels of protein structure.
We previously observed that the relatively large substitu-
ents of hydrotris(3-phenyl,5-methylpyrazolyl)borate (i.e.,
TpPh,Me) forced significant bending of a Ni(II)-SAr bond;
the observed bond angle increased from 103.84(8)ꢀ for
TpMe,MeNi-SPh (1) to 116.51(7)ꢀ for TpPh,MeNi-S-2,6-
Me2C6H3 (9) in respective X-ray crystal structures.9 The
arylthiolate coordination was otherwise quite similar in the
two complexes, with the thiophenolate sulfur displaced off
the 3-fold axis toward one pyrazole, and the aryl substituent
oriented vertically (i.e., aligned between 3-substituents on the
other two pyrazole rings). Several related complexes of
various tripodal borate ligands have been reported. Similar
vertical geometries were observed for TpiPr,iPrNi-SC6F5,13 an
analogous tripodal borate complex with thioether donors,14
and its C6H5S- congener.14 In contrast, a tripodal borate
with diphenylphosphinomethyl donor arms yielded a differ-
ent motif, with the sulfur atom disposed between donors and
the substituent significantly rotated toward horizontal,15 as
typically found for complexes with planar tetradentate sup-
porting ligands.16 Another class of [Ni(SAr)4]2- complexes
exhibits tetragonal (D2d) distortion,17-20 and a linear Ni(SAr)2
complex has also been reported.21 The distinctive features of
these structures demonstrate disparate coordination modes
for arylthiolates in pseudotetrahedral Ni(II) complexes.
In the present work, we probed arylthiolate ligation at
TpMe,MeNiII centers by selectively modifying the arylthiolate
on the parent TpMe,MeNi-SPh complex (1), either with
increasingly bulky ortho groups (2-5), or with electronically
significant para substituents (6-8). These complexes demon-
strate a primary role for steric interaction with the tris-
(pyrazolyl) pocket in eliciting two disparate arylthiolate
bonding modes, which have been structurally characterized
and distinguished by spectroscopy and density functional
theory (DFT) calculations.
NMR method in CDCl3 at 295 K.22 UV-visible-NIR spectra
were recorded on an Agilent HP-8453 diode-array spectrophot-
ometer. Elemental analyses were performed by Atlantic
Microlabs, Inc. (Norcross, GA). TpMe,MeNiCl was prepared
by metathesis of anhydrous NiCl2 and TlTpMe,Me in MeOH/
CH2Cl2 (Caution: thallium salts are extremely toxic and must be
properly handled and disposed of).23 2,6-Diphenyl- and 2,4,6-
tris(isopropyl)phenylthiol were prepared by literature
procedures,24-26 and other thiols were obtained from a com-
mercial vendor (Aldrich). The thiols were converted to respec-
tive sodium salts by titration of NaNH2 in toluene, and reacted
with TpMe,MeNiCl in tetrahydrofuran (THF) to obtain target
complexes in 65-80% yields following toluene extraction as
previously described.9 Characterizations of product complexes
are summarized below. All other materials were obtained from
commercial vendors as ACS reagent-grade or better and used as
received, except for drying of solvents by routine techniques.
TpMe,MeNi-SC6H5 (1).9 Anal. Calcd (found) for C21H27-
BN6NiS: C, 54.23 (54.64); H, 5.85 (5.98); N 18.07 (18.24).
UV-vis (CH2Cl2, λmax, nm; ε, mM-1 cm-1): 354 (1.6); 464
(2.4); 506 (2.6); 614 (sh, 0.2); 836 (0.2); 970 (sh, 0.1). 1H NMR
(CDCl3, 295 K; δ, ppm): 77.2 (3H, 4-pz); 23.3 (2H, meta); 6.6
(9H, 5-Me); -7.1 (9H, 3-Me); -10.7 (1H, B-H); -18.9 (2H,
ortho); -26.6 (1H, para); μeff = 2.92 μB.
TpMe,MeNi-S-2,6-Me2C6H3 (2). Anal. Calcd (found) for
C23H31BN6NiS H2O: C, 54.05 (54.24); H, 6.51 (6.71); N 16.44
3
(16.57). UV-vis (toluene, λmax, nm; ε, mM-1 cm-1): 342 (0.9);
368 (0.9); 411 (1.1); 471 (sh, 1.4); 511 (2.2); 640 (0.2); 856 (0.1);
958 (0.1). 1H NMR (CDCl3; δ, ppm): 75.3 (3H, 4-pz); 31.7 (6H,
ortho); 25.2 (2H, meta); 5.5 (9H, 5-Me); -7.5 (9H, 3-Me); -10.4
(1H, para); -11.3 (1H, B-H).
TpMe,MeNi-S-2,4,6-Me3C6H2 (3).9 Anal. Calcd (found) for
C24H33BN6NiS: C, 56.84 (56.75); H, 6.56 (6.59); N 16.57 (17.32).
UV-vis (CH2Cl2, λmax, nm; ε, mM-1 cm-1): 343 (1.1); 371 (1.1);
1
406 (1.2); 467 (sh, 1.5); 514 (2.7); 636 (sh, 0.2); 861 (0.2). H
NMR (CDCl3; δ, ppm): 75.0 (3H, 4-pz); 33.3 (6H, ortho); 25.8
(3H, para); 25.3 (2H, meta); 5.2 (9H, 5-Me); -7.5 (9H, 3-Me);
-11.3 (1H, B-H); μeff = 3.01 μB.
TpMe,MeNi-S-2,4,6-iPr3C6H2 (4). Anal. Calcd (found) for
C30H45BN6NiS: C, 60.94 (61.03); H, 7.67 (7.83); N 14.21
(14.25). UV-vis (CH2Cl2, λmax, nm; ε, mM-1 cm-1): 338 (sh,
1.1); 414 (2.2); 516 (2.8); 665 (0.3); 870 (0.2); 954 (0.1). 1H NMR
(CDCl3; δ, ppm): 75.3 (3H, 4-pz); 24.5 (2H, meta); 19.7 (2H, 2,6-
CHMe2); 8.8 (1H, 4-CHMe2); 8.0 (12H, 2,6-CHMe2); 5.3 (9H, 5-
Me); 2.3 (6H, 2,6-CHMe2); -8.1 (9H, 3-Me); -11.8 (1H, B-H).
TpMe,MeNi-S-2,6-Ph2C6H3 (5). Anal. Calcd (found) for
C33H35BN6NiS: C, 64.21 (64.27); H, 5.72 (5.79); N 13.62
(13.57). UV-vis (CH2Cl2, λmax, nm; ε, mM-1 cm-1): 357 (sh,
0.8); 422 (1.8); 516 (1.8); 657 (0.3); 867 (0.2); 942 (0.1). 1H NMR
(CDCl3; δ, ppm): 76.5 (3H, 4-pz); 24.6 (2H, meta); 15.1 (4H, 2,6-
ortho); 7.4 (2H, 2,6-para); 6.8 (4H, 2,6-meta); 5.9 (9H, 5-Me); 1.4
(1H, para); -9.4 (9H, 3-Me); -11.7 (1H, B-H); μeff = 2.89 μB.
TpMe,MeNi-S-C6H4-4-OCH3 (6). Anal. Calcd (found) for
C22H29BN6NiOS: C, 53.37 (53.46); H, 5.90 (5.89); N 16.98
(17.21). UV-vis (CH2Cl2, λmax, nm; ε, mM-1 cm-1): 348
(1.8); 484 (sh, 2.4); 517 (3.1); 843 (0.2); 1000 (sh, 0.1). 1H
NMR (CDCl3; δ, ppm): 75.5 (3H, 4-pz); 22.5 (2H, meta); 6.3
(9H, 5-Me); -6.9 (9H, 3-Me); -8.3 (3H, OMe); -10.3 (1H, B-
H); -21.0 (2H, ortho).
2. Experimental Methods
2.1. General and Synthetic Procedures. All manipulations
were carried out under an inert atmosphere of prepurified argon,
either in a glovebox (MBraun Unilab) or using Schlenk techni-
ques. 1H NMR data were recorded on a Varian Unity 500
spectrometer and processed using the MestReNova 5.1.0 soft-
ware suite (Mestrelab Research, Santiago de Compostela,
Spain); spectra were referenced internally to residual solvent.
Solution magnetic moments were determined by the Evans
(13) Matsunaga, Y.; Fujisawa, K.; Ibi, N.; Miyashita, Y.; Okamoto, K.-i.
Inorg. Chem. 2005, 44, 325–335.
(14) Cho, J.; Yap, G. P. A.; Riordan, C. G. Inorg. Chem. 2007, 46, 11308–
11315.
(15) MacBeth, C. E.; Thomas, J. C.; Betley, T. A.; Peters, J. C. Inorg.
Chem. 2004, 43, 4645–4662.
(16) Fox, D. C.; Fiedler, A. T.; Halfen, H. L.; Brunold, T. C.; Halfen, J. A.
J. Am. Chem. Soc. 2004, 126, 7627–7638.
TpMe,MeNi-S-C6H4-4-CH3 (7). Anal. Calcd (found) for
C22H29BN6NiS: C, 55.16 (55.18); H, 6.10 (6.16); N 17.54
(17) Swenson, D.; Baenziger, N. C.; Coucouvanis, D. J. Am. Chem. Soc.
1978, 100, 1932–1934.
(18) Rosenfield, S. G.; Armstrong, W. H.; Mascharak, P. K. Inorg. Chem.
1986, 25, 3014–3018.
(23) Santi, R.; Romano, A. M.; Sommazzi, A.; Grande, M.; Bianchini, C.;
Mantovani, G. J. Mol. Cat. A 2005, 229, 191–197.
(24) Blower, P. J.; Dilworth, J. R.; Hutchinson, J. P.; Zubieta, J. A.
J. Chem. Soc., Dalton Trans. 1985, 1533–1541.
(25) Newton, A. J. Am. Chem. Soc. 1943, 65, 2439–2441.
(26) Bishop, P. T.; Dilworth, J. R.; Nicholson, T.; Zubieta, J. J. Chem.
Soc., Dalton Trans. 1991, 385–392.
(19) Silver, A.; Koch, S. A.; Millar, M. Inorg. Chim. Acta 1993, 205, 9–14.
(20) Mueller, A.; Henkel, G. Z. Naturforsch. B 1995, 50, 1464–1468.
(21) Nguyen, T.; Panda, A.; Olmstead, M. M.; Richards, A. F.; Stender,
M.; Brynda, M.; Power, P. P. J. Am. Chem. Soc. 2005, 127, 8545–8552.
(22) Evans, D. F.; Jakubovic, D. A. J. Chem. Soc., Dalton Trans. 1988,
2927–2933.